We provide the latest news
from the world of economics and finance
(RTTNews) - Xencor, Inc. (XNCR), focused on cancer and other serious diseases, on Tuesday announced that it has appointed Bart Cornelissen as chief financial officer.
On October 26, 2023, the drug maker had announced its then CFO John Kuch's plan to retire in March 2024 after a 23 year career with the company.
With over 20 years of experience in corporate finance, Cornelissen was most recently Vice President, Corporate Finance at Seagen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.